Revised USP Chapter <1790> on Visual Inspection published
Recommendation

22/23 September 2026
Organisation of a GMP-compliant Site Change
After the long-awaited Chapter <1790> Visual Inspection of Injections was first published in the Pharmacopeial Forum 41(1) as a draft the USP has now submitted a revised draft in the PF41 (6). Through its number >1000, the monograph <1790> is not binding but rather offers an explanation to Chapter <790> Visible Particulates in Injections.
With regard to the content, several comments recommended by the industry have been included. The new Chapter 9 represents the biggest change and describes the evaluation of marketed products where anomalies had been observed regarding particles. The test procedure for it is described in Chapter <790>. Yet, this topic was missing in the original draft of Chapter <1790>. Thus, in total there is one more chapter. In addition, the underlying test statistics contained in the chapter on inspection of lyophilised product have been detailed. The requirements on the premises for manual inspection have also been added in more detail. Moreover, a clear statement can be found on the validation of a fully automatic system which should be based on the comparison with the compendial manual inspection.
The draft document is available for free on the website of the USP Pharmacopeial Forum. You only need to register for free. The deadline for comments is 31 Januar 2016. The new chapter could be published in the USP 40 in November 2016 and becomes effective as of May 2017. A document comparing the original and the second draft can be found on the website of ECA's Visual Inspection Group, under useful links.
Related GMP News
12.08.2026European Inspection uncovers serious Deficiencies at Indian Sterile Manufacturer
05.08.2026ASME BPE-2026: Overview of the Key Updates
05.08.2026Warning Letter to an Indian Manufacturer of OTC Products
29.07.2026What are the Requirements for the Manufacture of Solid Dosage Forms in Pharmaceutical Production?
29.07.2026WHO finalises Paper on Continuous Manufacturing
22.07.2026Deviations in Aseptic Manufacturing: Warning Letter to a Japanese Pharmaceutical Manufacturer


